Take the test?
I wouldn't take it.
IBM, Pfizer design AI model that can predict Alzheimer's in seemingly healthy patients
Oct. 22, 2020 3:24 PM ET|About: International Business Mach... (IBM)|By: Brandy Betz, SA News Editor
IBM (IBM +0.4%) and Pfizer (PFE +1.0%) have published research in The Lancet eClinicalMedicine outlining the duo's AI-backed approach to diagnosing Alzheimer's years before symptoms occur.
The researches developed an AI model that uses samples of language data (obtained from clinical cognitive verbal tests) to predict with 71% accuracy the eventual onset of the disease within seemingly healthy people who don't have any Alzheimer's risk factors.
IBM says the "work is part of a larger platform IBM Research is building to better understand neurological health and chronic illnesses through biomarkers and signals in speech and language."
I wouldn't take it.
IBM, Pfizer design AI model that can predict Alzheimer's in seemingly healthy patients
Oct. 22, 2020 3:24 PM ET|About: International Business Mach... (IBM)|By: Brandy Betz, SA News Editor
IBM (IBM +0.4%) and Pfizer (PFE +1.0%) have published research in The Lancet eClinicalMedicine outlining the duo's AI-backed approach to diagnosing Alzheimer's years before symptoms occur.
The researches developed an AI model that uses samples of language data (obtained from clinical cognitive verbal tests) to predict with 71% accuracy the eventual onset of the disease within seemingly healthy people who don't have any Alzheimer's risk factors.
IBM says the "work is part of a larger platform IBM Research is building to better understand neurological health and chronic illnesses through biomarkers and signals in speech and language."